一种纳米图,包括萨尔科佩尼亚和营养指标,用于预测HBV相关的急性慢性肝衰竭的死亡率
Jiao Yuan1, Wenting Peng1, Chuan Jiang1
1Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha 410008, China.
Healthcare (Basel, Switzerland)
|February 27, 2026
概括
通过将营养指标与传统因素相结合,一种新型的诺米图准确预测乙型肝炎病毒相关的急性至慢性肝衰竭 (HBV-ACLF) 患者的12周死亡率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临床预后 临床预后
- 营养科学 营养科学
背景情况:
- 急性至慢性肝衰竭 (ACLF) 的预后因不同地区的不同原因而有所不同.
- 现有的乙型肝炎病毒相关ACLF (HBV-ACLF) 的预后模型没有充分纳入营养标记.
研究的目的:
- 在HBV-ACLF患者中开发一个12周死亡率的预测性诺姆图.
- 将营养状况指标与传统预测指标相结合,以改善风险分层.
主要方法:
- 对242名成年HBV-ACLF患者的回顾性分析 (2020年5月 - 2021年12月).
- 后勤回归确定了独立的预后因素.
- 一个nomogram被构建并使用引导重抽样内部验证.
主要成果:
- 确定了六个独立的预测因素,包括营养标记 (L3骨肌指数,乳腺胺).
- 诺米图表表现出高预测精度 (AUC = 0.95) 和出色的校准.
- 通过决策曲线分析证实了临床效用.
结论:
- 这种新型名图有效地对HBV-ACLF的短期死亡风险进行了分层.
- 纳入营养状况可以提高临床决策的预后准确性.
- 该工具有助于管理等待肝移植的HBV-ACLF患者.
相关概念视频
Dosage Regimen Designs: Nomograms and Tabulations
264
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
264
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
